Log in to save to my catalogue

Chlorambucil targets BRCA 1/2‐deficient tumours and counteracts PARP inhibitor resistance

Chlorambucil targets BRCA 1/2‐deficient tumours and counteracts PARP inhibitor resistance

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2251963637

Chlorambucil targets BRCA 1/2‐deficient tumours and counteracts PARP inhibitor resistance

About this item

Full title

Chlorambucil targets BRCA 1/2‐deficient tumours and counteracts PARP inhibitor resistance

Publisher

Frankfurt: EMBO Press

Journal title

EMBO molecular medicine, 2019-07, Vol.11 (7)

Language

English

Formats

Publication information

Publisher

Frankfurt: EMBO Press

More information

Scope and Contents

Contents

Due to compromised homologous recombination (HR) repair, BRCA1‐ and BRCA2‐mutated tumours accumulate DNA damage and genomic rearrangements conducive of tumour progression. To identify drugs that target specifically BRCA2‐deficient cells, we screened a chemical library containing compounds in clinical use. The top hit was chlorambucil, a bifunctiona...

Alternative Titles

Full title

Chlorambucil targets BRCA 1/2‐deficient tumours and counteracts PARP inhibitor resistance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2251963637

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2251963637

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.201809982

How to access this item